drugset / Trial / NCT02034773
3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule
RandomizedSingle-groupDouble-blind
Summary
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of CC-220 in healthy subjects and to evaluate the relative bioavailability of a formulated CC-220 capsule
Timeline
- Start
- 2013-05
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iberdomide | Small molecule | 0.3 mg | Oral |
| Subject | Iberdomide | Small molecule | 1 mg | Oral |
Indications
No indication recorded.